Related Experiment Video
Updated: Jan 30, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Thymidine phosphorylase promotes malignant progression in hepatocellular carcinoma through pentose Warburg effect
Qiang Zhang1,2, Yuan Qin1,2, Jianmin Zhao3
1State Key Laboratory of Medicine Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
Abstract:
Tumor progression is dependent on metabolic reprogramming. Metastasis and vasculogenic mimicry (VM) are typical characteristics of tumor progression. The relationship among metastasis, VM, and metabolic reprogramming remains unclear. In this study, we identified the novel role of Twist1, a VM regulator, in the transcriptional regulation of thymidine phosphorylase (TP) expression. TP promoted the extracellular metabolism of thymidine into ATP and amino acids through the pentose Warburg effect by coupling the pentose phosphate pathway and glycolysis. Moreover, Twist1 relied on TP-induced metabolic reprogramming to promote hepatocellular carcinoma (HCC) metastasis and VM formation mediated by VE-Cad, VEGFR1, and VEGFR2 in vitro and in vivo. The TP inhibitor tipiracil reduced the effect of TP on promoting HCC VM formation and metastasis. Hence, TP, when transcriptionally activated by Twist1, promotes HCC VM formation and metastasis through the pentose Warburg effect and contributes to tumor progression.
Related Concept Videos
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Anaphase Promoting Complex
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...

